Keywords: سندرم لینچ; Immunotherapy; Lynch syndrome; Mismatch repair; PD-1 inhibitors;
مقالات ISI سندرم لینچ (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سندرم لینچ; Sebaceous carcinoma; Mature cystic teratoma; Dermoid cyst; Lynch syndrome; Muir-Torre syndrome; Hereditary nonpolyposis colorectal cancer (HNPCC);
Keywords: سندرم لینچ; Case report; Triple primary malignancies; Colorectal carcinoma; Lynch syndrome; Genetic testing;
Keywords: سندرم لینچ; Lynch syndrome; Endometrial biopsy; Endometrial carcinoma; Immunohistochemistry;
Keywords: سندرم لینچ; Lynch syndrome; Endometrial cancer; Genetic counseling; Mismatch repair;
Keywords: سندرم لینچ; Lynch syndrome; Ovarian cancer; Surveillance; Survival;
Keywords: سندرم لینچ; Lynch syndrome; Endometrial cancer; Ovarian cancer; Endometrial hyperplasia; Hypermethylation; Mismatch repair;
Keywords: سندرم لینچ; Endometrial cancer; MMR defect; Lynch syndrome; Targeted sequencing; ARID1A; MLH1 silencing;
Keywords: سندرم لینچ; Familial colon cancer; hereditary polyposis syndrome; genetic defect; AFAP; attenuated familial adenomatous polyposis; CS; Cowden syndrome; FAP; familial adenomatous polyposis; JPS; juvenile polyposis syndrome; LS; Lynch syndrome; MAP; MUTYH-associated po
Keywords: سندرم لینچ; Hereditary diffuse gastric cancer; Lynch syndrome; Hereditary nonpolyposis colorectal cancer; Familial adenomatous polyposis; Gastric adenocarcinoma and proximal polyposis of the stomach; Peutz-Jeghers syndrome; Juvenile polyposis syndrome; Cowden syndrom
Keywords: سندرم لینچ; urinary tract; urothelium; carcinoma; colorectal neoplasms; hereditary nonpolyposis; genetic testing; AMS; Amsterdam criteria; EAU; European Association of Urology; GAC; genetic assessment and counseling; IHC; immunohistochemistry; LS; Lynch syndrome; MMR
Keywords: سندرم لینچ; Double somatic mutations; Biallelic mutations; Lynch syndrome; MMR deficiency; Lynch-like syndrome;
Keywords: سندرم لینچ; Hereditary cancer syndrome; BRCA; Lynch syndrome; Screening; Risk reduction;
Keywords: سندرم لینچ; Lynch syndrome; Colorectal cancer; Colorectal surgery;
Keywords: سندرم لینچ; Lynch syndrome; Multigene panel sequencing; Polyposis syndromes; Variant classification;
Keywords: سندرم لینچ; cutaneous T-cell lymphoma; hereditary nonpolyposis colon cancer; Lynch syndrome; microsatellite instability; MLH1; Muir-Torre syndrome; MSH2; mycosis fungoides; ECP; extracorporeal photopheresis; HNPCC; hereditary nonpolyposis colorectal carcinoma; ICL; i
Keywords: سندرم لینچ; Lynch Syndrome; Genetics; Screening; Colorectal cancer; Testing; SÃndrome de Lynch; Genética; Triagem; Câncer colorretal; Testes;
Keywords: سندرم لینچ; Endometrial cancer; Family cancer history; Lynch syndrome; Mismatch repair; Risk;
Keywords: سندرم لینچ; Lynch syndrome; Family communication; Patient education;
Keywords: سندرم لینچ; aCGH; array comparative genomic hybridization; CIMP; CpG island methylator phenotype; CIN; chromosomal instability; CNA; copy number alteration; CRC; colorectal cancer; DFS; disease-free survival; EOCRC; early-onset colorectal cancer; GII; genomic Instabi
Keywords: سندرم لینچ; Lynch syndrome; Endometrial cancer; Lynch-like case; Gastric cancer; Immunohistochemistry;
Keywords: سندرم لینچ; Lynch syndrome; mismatch repair; Lynch-like syndrome;
Keywords: سندرم لینچ; Lynch syndrome; Familial Congolese colorectal cancer; Bethesda/Amsterdam II criteria; Mismatch repair genes; Syndrome de Lynch; Cancer colorectal familial congolais; Critères de Bethesda/Amsterdam II; Gènes Mismatch repair;
Keywords: سندرم لینچ; Familial cancer; Colorectal cancer; Lynch syndrome; FAP;
Keywords: سندرم لینچ; Mismatch repair deficiency; Lynch syndrome; Immune checkpoint; Nivolumab; Endometrial cancer; Colorectal cancer; Cancer de l'endomètre; Cancer colorectal; Checkpoint immunitaires; Déficience du système de réparation de l'ADN; Nivolumab; Syndrome d
Keywords: سندرم لینچ; BRCA; cervical cancer; endometrial cancer; hereditary cancer; high risk; Lynch syndrome; ovarian cancer; risk reduction; screening;
Keywords: سندرم لینچ; Hereditary breast and ovarian cancer syndrome; Lynch syndrome; melanoma; prostate cancer; genetic testing; pan-cancer panel;
Keywords: سندرم لینچ; BRCA1; BRCA2; Lynch syndrome; ovarian cancer; uterine cancer; high-throughput DNA sequencing;
Keywords: سندرم لینچ; AC; Amsterdam criteria; AFAP; attenuated familial adenomatous polyposis; APC; adenomatous polyposis coli; CAP; College of American Pathologists; CD; Crohn disease; CLIA; Clinical Laboratory Improvement Amendments; CRC; colorectal cancer; dMMR; deficient m
Keywords: سندرم لینچ; Inherited colon cancer; Hereditary nonpolyposis colorectal cancer; Lynch syndrome; Familial adenomatous polyposis; MUTYH-associated polyposis; Serrated polyposis syndrome;
Keywords: سندرم لینچ; Endometrial carcinoma; Lynch syndrome; Mismatch repair; Germline; Lynch-like syndrome;
Keywords: سندرم لینچ; Lynch syndrome; Immunohistochemistry; Pitfalls; Staining pattern;
Keywords: سندرم لینچ; Prevención; SÃndrome de Lynch; Poliposis colorrectal; Neoplasia colorectal; Prevention; Lynch syndrome; Colorectal polyposis; Colorectal neoplasia;
Keywords: سندرم لینچ; Microsatellite instability; Colorectal cancer; Lynch syndrome; Immunotherapy; Predictive;
Keywords: سندرم لینچ; InmunohistoquÃmica; Adenoma; SÃndrome de Lynch; Cáncer colorrectal; Displasia de alto grado; Immunohistochemistry; Adenoma; Lynch syndrome; Colorectal cancer; High grade dysplasia;
Keywords: سندرم لینچ; LS; Lynch syndrome; CRC; colorectal cancer; HNPCC; hereditary non-polyposis colon cancer; MMR; mismatch repair; FAP; familial adenomatous polyposis; CFS; cancer family syndrome; MSI; microsatellite instability; IDL; insertion/deletion loop; MSH2; human mu
Keywords: سندرم لینچ; DNA Mismatch Repair; Microsatellite Instability; Lynch Syndrome; Colorectal Cancer; Minority; Medically Underserved Populations; ADC; adenocarcinoma; AJCC; American Joint Committee on Cancer; black; black non-Hispanic; CI; confidence interval; CRC; colore
Keywords: سندرم لینچ; Lynch syndrome; Ovarian cancer; Surveillance; Screening; Systematic review;
Keywords: سندرم لینچ; Pancreatic cancer; Hereditary; Screening; Peutz-Jeghers; BRCA; Lynch syndrome; IPMN; PanIN;
Keywords: سندرم لینچ; Lynch syndrome; Endometrial cancer; Molecular diagnostic testing;
Keywords: سندرم لینچ; Rare tumor; Small intestine adenocarcinoma; Carcinogenesis; Lynch syndrome; Prognostic factor; Chemotherapy;
Keywords: سندرم لینچ; Ovarian cancer; Endometrial cancer; Lynch syndrome; Hereditary cancer; BRCA1/2;
Keywords: سندرم لینچ; Chemoprevention; Hereditary cancer; Lynch syndrome; Li-Fraumeni syndrome; HBOC;
Keywords: سندرم لینچ; Predictive Markers; Prognostic Markers; Colorectal Cancer; Molecular Subtypes; RAS; BRAF; MSI; DNA Mismatch Repair; Immunotherapy; Targeted Therapy; Biologics; Anti-EGFR; Anti-VEGF; CCS; colon cancer subtypes; CIMP; CpG island methylator phenotype; CIN; c
Keywords: سندرم لینچ; Lynch syndrome; Endometrial cancer; Hereditary nonpolyposis colorectal neoplasms; Questionnaires; Genetic testing; Family history;
Keywords: سندرم لینچ; Barrettʼs esophagus; Inflammatory bowel disease; Serrated polyps; Lynch syndrome; p53;
Keywords: سندرم لینچ; Colorectal cancer; Hereditary nonpolyposis colorectal cancer; Lynch syndrome; Familial adenomatous polyposis; MUTYH-associated polyposis;
Keywords: سندرم لینچ; Colonoscopy; Colorectal cancer; Colonic polyps; Surveillance; Adenoma; Lynch syndrome; Inflammatory bowel disease; Molecular imaging; Lectins;
Keywords: سندرم لینچ; Hereditary colon cancer; Lynch syndrome; Familial adenomatous polyposis; MUTYH-associated polyposis; Peutz-Jeghers syndrome; Juvenile polyposis;
Keywords: سندرم لینچ; Hereditary Nonpolyposis Colorectal Cancer; HNPCC; Colon Cancer Genetics; Inherited Cancer; CI; confidence interval; CRC; colorectal cancer; EC; endometrial cancer; HBOC; hereditary breast/ovarian cancer; IHC; immunohistochemistry; LS; Lynch syndrome; MMR;